Is the party over for the shares of Blackmores Limited and Bellamy's Australia Ltd?

Shares in Blackmores Limited (ASX:BKL) and Bellamy's Australia Ltd (ASX:BAL) are 115% and 202% higher respectively over the past year.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last week the share price of leading vitamin and health supplement manufacturer Blackmores Limited (ASX: BKL) slumped nearly 13% to close Friday's trading session at $158.69.

It was also a disappointing week for shareholders in infant formula marketer Bellamy's Australia Ltd (ASX: BAL), which fell just over 11% to close at $10.36.

In comparison, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) managed to eke out a weekly gain of 0.6%.

While Blackmores and Bellamy's are two businesses which are undoubtedly enjoying tailwinds – thanks in no small part to fast growing demand from Chinese customers – it's possible that the market is starting to question whether these positive outlooks are already more than fully reflected in the current share prices of these two market darlings.

Indeed, the share prices of Blackmores and Bellamy's Australia are 115% and 202% higher respectively over the past year.

Based on data supplied by Reuters, the average estimates of analysts covering Blackmores suggests earnings per share (EPS) are set to rocket from a forecast 600 cents per share (cps) in financial year (FY) 2016 to 731 cps in FY 2017.

Based on the above FY 2017 consensus forecast, Blackmores is trading on a price-to-earnings (PE) multiple of around 22 times. Arguably that is a reasonable multiple which reflects the increased competition that Blackmores will undoubtedly face.

Similarly, the EPS growth of Bellamy's is expected to be spectacular with consensus forecasts showing a jump from 38 cps in FY 2016 to 66 cps in FY 2017.

Based on the FY 2017 forecast, Bellamy's is trading on a PE of approximately 16 times. This multiple would appear to suggest that the market is taking quite a dim view as to the sustainability of Bellamy's above average growth rates.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia owns shares of Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »